What might a nurse assess for in a client receiving gentamicin for pelvic inflammatory disease?

In clients receiving gentamicin, particularly for conditions such as pelvic inflammatory disease, one important aspect for the nurse to assess is changes in hearing ability. Gentamicin is an aminoglycoside antibiotic known for its potential ototoxic effects, which can lead to hearing loss or balance issues due to its impact on the inner ear structures. This risk is particularly relevant in prolonged therapy or in patients with existing renal impairment, which can enhance the drug's toxicity.

While monitoring other factors such as blood pressure, signs of renal impairment, and heart rate is certainly part of comprehensive nursing care, they do not specifically relate to the immediate and primary concerns associated with gentamicin administration. Changes in hearing ability are critical to catch early, as they may indicate the onset of ototoxicity, which needs to be addressed promptly to prevent permanent damage.